Capital Fund Management (CFM)
TPTX

Capital Fund Management (CFM)’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Capital Fund Management (CFM)’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,864
Closed -$1.5M – 1717
2021
Q1 		$1.5M Buy
+15,864
New +$1.89M 0.02% 843

Other funds holding TPTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Capital Fund Management (CFM)'s TPTX Position: Q2 2021 in Review

Capital Fund Management (CFM) sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q2 2021, closing a stake of 15,864 shares — an estimated $1.5M sold.

Capital Fund Management (CFM) first reported a position in TPTX in Q1 2021 and held it in 1 quarter. The position peaked at $1.5M in Q1 2021. 190 funds tracked by Wall St. Rank hold TPTX as of Q2 2021.

  • Capital Fund Management (CFM) reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 15,864 Turning Point Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $1.5M.
  • Capital Fund Management (CFM) first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Capital Fund Management (CFM)'s Turning Point Therapeutics, Inc. Common Stock position peaked at $1.5M in Q1 2021.
  • 190 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2021, filed 12 Aug 2021.